Nancy Bouvier

6.2k total citations · 1 hit paper
27 papers, 1.7k citations indexed

About

Nancy Bouvier is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Nancy Bouvier has authored 27 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Nancy Bouvier's work include Cancer Genomics and Diagnostics (7 papers), Acute Myeloid Leukemia Research (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Nancy Bouvier is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Acute Myeloid Leukemia Research (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Nancy Bouvier collaborates with scholars based in United States, Canada and Austria. Nancy Bouvier's co-authors include Klaus Griewank, Gary Green, Raya Khanin, María C. Garrido, Michael R. Speicher, Mert Sozen, Klaus J. Busam, Michelle B. Crosby, Joan M. O’Brien and Igor Dolgalev and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Nancy Bouvier

24 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutations in GNA11 in Uveal Melanoma

2010 1.1k citations Catherine D. Van Raamsdonk, Klaus Griewank et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy Bouvier United States	12	827	794	619	329	274	27	1.7k
R. Cavaliere Italy	19	520 0.6×	558 0.7×	119 0.2×	237 0.7×	410 1.5×	51	1.6k
Michael R. Pins United States	26	660 0.8×	870 1.1×	43 0.1×	729 2.2×	149 0.5×	68	2.3k
Allen Buxton United States	21	977 1.2×	1.0k 1.3×	31 0.1×	231 0.7×	381 1.4×	49	3.1k
Annette Zimpfer Germany	18	366 0.4×	267 0.3×	57 0.1×	123 0.4×	119 0.4×	61	961
Neerav Shukla United States	21	519 0.6×	906 1.1×	50 0.1×	77 0.2×	90 0.3×	78	1.7k
Irina A. Lubensky United States	26	635 0.8×	1.1k 1.3×	47 0.1×	454 1.4×	71 0.3×	41	2.2k
Kwan Y. Wong United States	15	482 0.6×	1.1k 1.4×	41 0.1×	196 0.6×	150 0.5×	30	2.5k
Metin Özdemirli United States	23	470 0.6×	678 0.9×	17 0.0×	222 0.7×	217 0.8×	82	1.7k
Makiko Itami Japan	20	636 0.8×	357 0.4×	27 0.0×	230 0.7×	194 0.7×	89	1.7k
Dong Won Kim South Korea	18	461 0.6×	296 0.4×	29 0.0×	270 0.8×	89 0.3×	66	1.1k

Countries citing papers authored by Nancy Bouvier

Since Specialization

Citations

This map shows the geographic impact of Nancy Bouvier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Bouvier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Bouvier more than expected).

Fields of papers citing papers by Nancy Bouvier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Bouvier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Bouvier. The network helps show where Nancy Bouvier may publish in the future.

Co-authorship network of co-authors of Nancy Bouvier

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Bouvier. A scholar is included among the top collaborators of Nancy Bouvier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Bouvier. Nancy Bouvier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Friedman, Danielle Novetsky, Chaya S. Moskowitz, Kimberly L. Turner, et al.. (2023). Clonal hematopoiesis in survivors of childhood cancer. Blood Advances. 7(15). 4102–4106. 13 indexed citations

Buckley, Michael, et al.. (2023). Integrating technology to support data management abstraction of adverse events (AE) and concomitant medications (ConMed) from the electronic health record (EHR) to sponsor electronic data capture (EDC) systems using design thinking (DT) methodology.. Journal of Clinical Oncology. 41(16_suppl). e13624–e13624.

Friedman, Danielle Novetsky, Chaya S. Moskowitz, Kimberly L. Turner, et al.. (2023). Clonal hematopoiesis in survivors of childhood cancer.. Journal of Clinical Oncology. 41(16_suppl). 10014–10014. 1 indexed citations

Bouvier, Nancy, Jinru Shia, Anita P. Price, et al.. (2021). Identification of a TP53 Deletion in an Undifferentiated Embryonal Sarcoma of the Liver Provides Clinically Relevant Longitudinal Detection of Circulating Tumor DNA. JCO Precision Oncology. 5(5). 1421–1425. 1 indexed citations

Spitzer, Barbara, Filemon S. Dela Cruz, Yanming Zhang, et al.. (2021). ETV6-FLT3–positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML. Blood Advances. 5(7). 1899–1902. 10 indexed citations

Shukla, Neerav, Max F. Levine, Gunes Gundem, et al.. (2021). Feasibility and clinical utility of cancer whole genome and transcriptome sequencing for pediatric and young adult solid tumors.. Journal of Clinical Oncology. 39(15_suppl). 3063–3063.

Miller, Alexandra, Luca Szalontay, Nancy Bouvier, et al.. (2020). BIOM-56. THE INTEGRATION OF A LIQUID BIOPSY PROGRAM INTO THE CARE OF PEDIATRIC BRAIN TUMOR PATIENTS. Neuro-Oncology. 22(Supplement_2). ii13–ii14.

Perera, D. S., Ronald Ghossein, Niedzica Camacho, et al.. (2019). Genomic and Transcriptomic Characterization of Papillary Microcarcinomas With Lateral Neck Lymph Node Metastases. The Journal of Clinical Endocrinology & Metabolism. 104(10). 4889–4899. 27 indexed citations

Diolaiti, Daniel, Filemon S. Dela Cruz, Gunes Gundem, et al.. (2018). A recurrent novel MGA–NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma. Molecular Case Studies. 4(6). a003194–a003194. 39 indexed citations

10.

Murali, Rajmohan, Pier Selenica, David N. Brown, et al.. (2018). Somatic genetic alterations in synchronous and metachronous low‐grade serous tumours and high‐grade carcinomas of the adnexa. Histopathology. 74(4). 638–650. 20 indexed citations

11.

Teo, Min Yuen, Richard Bambury, Emily C. Zabor, et al.. (2017). DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma. Clinical Cancer Research. 23(14). 3610–3618. 189 indexed citations

12.

Scott, Sasinya N., Irina Ostrovnaya, Nancy Bouvier, et al.. (2017). Next‐generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non–muscle‐invasive urothelial carcinoma treated with bacille Calmette‐Guérin. Cancer Cytopathology. 125(6). 416–426. 23 indexed citations

13.

Janjigian, Y. Y., Francisco Sánchez-Vega, Philip Jonsson, et al.. (2016). Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade. Annals of Oncology. 27. vi208–vi208. 3 indexed citations

14.

Carmona, Francesc, David M. Hyman, Gary A. Ulaner, et al.. (2016). Abstract 298: Amplification of mutant ERBB2 drives resistance to the irreversible kinase inhibitor neratinib in ERBB2-mutated breast cancer patients. Cancer Research. 76(14_Supplement). 298–298. 1 indexed citations

15.

Tan, Marcus, Olca Baştürk, Umesh Bhanot, et al.. (2015). GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma. Journal of the American College of Surgeons. 220(5). 845–854e1. 131 indexed citations

16.

Bambury, Richard, Emmet Jordan, Emily C. Zabor, et al.. (2015). Association of somatic mutations in DNA damage repair (DDR) genes with efficacy of platinum-based chemotherapy in advanced urothelial carcinoma.. Journal of Clinical Oncology. 33(15_suppl). 4532–4532. 3 indexed citations

17.

Janjigian, Yelena Y., Efsevia Vakiani, Geoffrey Y. Ku, et al.. (2015). Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer. PLoS ONE. 10(8). e0134731–e0134731. 34 indexed citations

18.

Raamsdonk, Catherine D. Van, Klaus Griewank, Michelle B. Crosby, et al.. (2010). Mutations in GNA11 in Uveal Melanoma. New England Journal of Medicine. 363(23). 2191–2199. 1053 indexed citations breakdown →

19.

Holmes, Tyson H., Wenwei Tu, Xiaosong He, et al.. (2007). Humoral and Cellular Immune Responses in Children Given Annual Immunization With Trivalent Inactivated Influenza Vaccine. The Pediatric Infectious Disease Journal. 26(2). 107–115. 36 indexed citations

20.

Bouvier, Nancy, et al.. (2007). [Primitive metastasizing bronchial carcinoid with long survival].. PubMed. 24(1). 63–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact